文献速递类风湿关节炎

影响临床医生为炎症性关节炎开具改善病情抗风湿药的因素:定性研究的系统评价与主题综合

Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
PubMed 文献 · Semin Arthritis Rheum · 2022-02-27

该系统评价与主题综合纳入15项定性或混合方法研究、共716名临床医生(683名风湿科医生、27名护士、6名药师),覆盖10个国家,均聚焦类风湿关节炎管理。共识别6个主题,其中4个主题的GRADE-CERQual证据置信度为中等,涉及患者特征与偏好、医生经验与习惯、问诊时间压力、药物费用与报销复杂性、患者教育及同事意见等因素。

要点

  • 风湿科医生处方DMARD受患者特征、偏好、症状及药物不良反应影响。
  • 医生知识、经验、习惯与主观判断是处方行为的强驱动因素。
  • 问诊时间不足与药物费用报销复杂性是限制处方的系统因素。

核心结论

  • 针对上述因素的质量改进策略可能支持类风湿关节炎的最佳药物治疗,并可能适用于其他类型炎症性关节炎。

研究设计与样本

  • 系统评价与主题综合,纳入定性或混合方法研究,对象为风湿科医生、护士或药师,涉及任何DMARD和/或糖皮质激素处方,检索MEDLINE、Embase和EBSCOhost CINAHL Plus自建库至2021年6月15日。
  • 共纳入15项研究,涉及716名临床医生(683名风湿科医生、27名护士、6名药师),覆盖10个国家,均聚焦类风湿关节炎患者管理。
  • 由两名评价作者独立筛选研究,使用Critical Appraisal Skills Programme清单评估方法学质量,并提取与主题综合数据,采用GRADE-CERQual方法评价合成主题的置信度。

主要发现

  • 识别6个主题:风湿科医生处方受患者特征、偏好、症状及药物不良反应影响;医生知识、经验、习惯与主观判断是处方行为的强驱动因素;问诊时间高需求阻碍共享决策;药物费用与报销安排的复杂性限制处方选择;临床医生认识到提供药物选择患者教育的重要性;临床医生重视同事意见与支持以指导处方决策。
  • 多数主题(n=4)的GRADE-CERQual置信度评为中等,反映其可能合理代表影响类风湿关节炎患者DMARD处方的因素。
  • 问诊时间高需求与药物费用报销安排的复杂性属于系统因素,可能或可能不易改变。

关键数值与推荐

  • 纳入标准:使用定性或混合方法;风湿科医生、护士或药师视角;处方任何DMARD(传统合成[cs]、靶向合成[ts]、生物制剂[b]、生物类似药)和/或糖皮质激素;任何国家的任何医疗环境。

临床怎么用

  • 作者认为,针对上述因素的质量改进策略可能支持类风湿关节炎的最佳药物治疗,并可能适用于其他类型炎症性关节炎。
  • 作者认为,易于获取的、包含通俗摘要和治疗算法的现行国家指南可能解决部分主题。

局限性

  • 问诊时间高需求与药物费用报销安排的复杂性是系统因素,可能或可能不易改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Understanding factors that influence prescribing of disease-modifying anti-rheumatic drugs (DMARDs) will inform strategies to optimise care of people with inflammatory arthritis. We performed a systematic review and thematic synthesis of qualitative studies to explore these factors. Inclusion criteria were: use of qualitative or mixed methods; rheumatologist, nurse or pharmacist perspectives; prescription of any DMARD (conventional [cs], targeted synthetic [ts], biologic [b], biosimilars) and/or glucocorticoids; in any healthcare setting in any country. MEDLINE, Embase and EBSCOhost CINAHL Plus were searched from inception to 15 June 2021. Pairs of review authors independently identified studies for inclusion, assessed methodological quality using the Critical Appraisal Skills Programme checklist, and extracted and thematically synthesised data. Confidence in synthesis themes was evaluated using the GRADE Confidence in Evidence from Reviews of Qualitative research (CERQual) approach. We included 15 studies involving 716 clinicians (683 rheumatologists, 27 nurses, 6 pharmacists) across 10 countries, all focusing on management of patients with rheumatoid arthritis (RA). Six themes were identified: Rheumatologist prescribing is influenced by patients' characteristics, preferences, symptoms and negative responses to medication; Rheumatologist knowledge, experience, habits and subjective judgements are strong drivers of prescribing behaviour; High demands on consultation time impede shared decision-making; Costs and complexity of medication funding arrangements limit prescribing options; Clinicians recognise the importance of providing patient education about medication options; and Clinicians value colleagues' opinions and support to inform prescribing decisions. The majority of themes were graded as moderate confidence (n = 4), reflecting they are likely to reasonably represent the factors influencing prescribing of DMARDs to people with RA. Quality improvement strategies that address these factors are likely to support best practice pharmacologic management of RA and may be potentially applicable to other types of inflammatory arthritis. High demand on consultation time and complexity of medication funding arrangements are system factors that may or may not be amenable to change. Easily accessible living national guidelines which include lay summaries and treatment algorithms to support prescribing decisions may address some of the themes.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Lalor AF, Brooker JE, Rozbroj T, et al. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Semin Arthritis Rheum. 2022. PMID: 35286905. doi:10.1016/j.semarthrit.2022.151988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。